Peripheral T-Cell Lymphoma: Moving Toward Targeted Therapies.
Sign Up to like & getrecommendations! Published in 2019 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2019.04.002
Abstract: Therapeutic advances for peripheral T-cell non-Hodgkin lymphoma (PTCL) have lagged behind their B-cell NHL counterparts in part because novel agents to treat PTCL have been developed empirically. The recent clinical success of brentuximab-vedotin suggests that… read more here.
Keywords: cell lymphoma; peripheral cell; cell; toward targeted ... See more keywords
Adamantinomatous craniopharyngioma: moving toward targeted therapies.
Sign Up to like & getrecommendations! Published in 2020 at "Neurosurgical focus"
DOI: 10.3171/2019.10.focus19705
Abstract: The evolving characterization of the biological basis of adamantinomatous craniopharyngioma (ACP) has provided insights critical for novel systemically delivered therapies. While current treatment strategies for ACP are associated with low mortality rates, patients experience severely… read more here.
Keywords: adamantinomatous craniopharyngioma; craniopharyngioma moving; treatment; targeted therapies ... See more keywords
Toward Targeted Therapies in Oesophageal Cancers: An Overview
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14061522
Abstract: Simple Summary Prognosis for patients with oesophageal cancer is poor, because of its aggressive nature and the lack of targeted therapies. Advances in cancer biology and sequencing technology have enabled the selection of targeted therapies… read more here.
Keywords: cancer; toward targeted; targeted therapies; patients oesophageal ... See more keywords